Oligoastrocytoma classification: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
Line 17: Line 17:
{{Family tree |boxstyle=background: #F5F5F5;| C01 | | | | C02 |C01=<div style="width: 15em; padding:1em;"> '''Oligoastrocytoma (OAII)'''</div>| C02=<div style="width: 15em; padding:1em;"> '''Anaplastic oligoastrocytoma (OAIII)'''</div>}}
{{Family tree |boxstyle=background: #F5F5F5;| C01 | | | | C02 |C01=<div style="width: 15em; padding:1em;"> '''Oligoastrocytoma (OAII)'''</div>| C02=<div style="width: 15em; padding:1em;"> '''Anaplastic oligoastrocytoma (OAIII)'''</div>}}
{{Family tree/end}}
{{Family tree/end}}
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
[Group1]
[Group2]
[Group3]
[Group4]
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
[Classification method 1]
[Classification method 2]
[Classification method 3]
[Disease name] may be classified into several subtypes based on:
[Classification method 1]
[Classification method 2]
[Classification method 3]
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].


==Reference==
==Reference==

Revision as of 12:18, 18 July 2019

Oligoastrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligoastrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligoastrocytoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligoastrocytoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligoastrocytoma classification

CDC on Oligoastrocytoma classification

Oligoastrocytoma classification in the news

Blogs on Oligoastrocytoma classification

Directions to Hospitals Treating Glioma

Risk calculators and risk factors for Oligoastrocytoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Oligoastrocytoma may be classified according to the WHO classification of the central nervous system tumors into two subtypes: oligoastrocytoma (OAII) and anaplastic oligoastrocytoma (OAIII).[1]

Classification

Oligoastrocytoma may be classified according to the WHO classification of the central nervous system tumors into two subtypes:[1]


 
 
 
WHO classification of tumors of CNS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WHO grade II
 
 
 
WHO grade III
 
 
 
 
 
 
 
 
 
 
 
 
 
Oligoastrocytoma (OAII)
 
 
 
Anaplastic oligoastrocytoma (OAIII)


There is no established system for the classification of [disease name].


OR


[Disease name] may be classified according to [classification method] into [number] subtypes/groups:


[Group1]

[Group2]

[Group3]

[Group4]

OR


[Disease name] may be classified into [large number > 6] subtypes based on:


[Classification method 1]

[Classification method 2]

[Classification method 3]

[Disease name] may be classified into several subtypes based on:


[Classification method 1]

[Classification method 2]

[Classification method 3]

OR


Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.


OR


If the staging system involves specific and characteristic findings and features:


According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].


OR


The staging of [malignancy name] is based on the [staging system].


OR


There is no established system for the staging of [malignancy name].

Reference

  1. 1.0 1.1 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A; et al. (2007). "The 2007 WHO classification of tumours of the central nervous system". Acta Neuropathol. 114 (2): 97–109. doi:10.1007/s00401-007-0243-4. PMC 1929165. PMID 17618441.


Template:WikiDoc Sources